View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

Notice Summary

Title:
UK-Belfast: QUB/1820/19 Development of a Liposomal Formulation of a Peptide for Inhalation
Document Ref:
GB003ZM293933
Document Type:
Contract Notice - Other
Published By:
Queen’s University Belfast
Date Published:
19 April 2019
Deadline Date:
02 June 2019
Document Source:
Framework/DPS:
No
Alert Profile:
Labels:

Notice Abstract

The iABC-consortium (inhaled Antibiotics in Bronchiectasis and Cystic fibrosis) brings together world leading researchers to develop new antibiotic treatment options for people with Cystic Fibrosis (CF) and Bronchiectasis (BE), by sharing expertise and resources. The iABC program provides a unique opportunity to address a critical bottleneck in the development of antimicrobial agents for the treatment of chronic lung infection in CF and BE patients. This work has the potential to deliver new treatments which will improve quality of life and survival of CF and BE patients. As part of this program, Queens University Belfast seeks to appoint an Economic Operator to provide services to conduct Liposomal Formulation of a Peptiide for Inhalation sponsored by Polyphor Ltd.

Notice Details

CONTRACT NOTICE – NATIONAL

SERVICES

1 Authority Details

1.1

Authority Name and Address

Queen’s University Belfast
N/A
Belfast UK
Gillian Wasson N/A
N/A

1.2

Address from which documentation may be obtained

As in 1.1

1.3

Completed documents must be returned to:

As in 1.1

2 Contract Details

2.1

Title

QUB/1820/19 Development of a Liposomal Formulation of a Peptide for Inhalation

2.2

Description of the goods or services required

The iABC-consortium (inhaled Antibiotics in Bronchiectasis and Cystic fibrosis) brings together world leading researchers to develop new antibiotic treatment options for people with Cystic Fibrosis (CF) and Bronchiectasis (BE), by sharing expertise and resources.

The iABC program provides a unique opportunity to address a critical bottleneck in the development of antimicrobial agents for the treatment of chronic lung infection in CF and BE patients. This work has the potential to deliver new treatments which will improve quality of life and survival of CF and BE patients.

As part of this program, Queens University Belfast seeks to appoint an Economic Operator to provide services to conduct Liposomal Formulation of a Peptiide for Inhalation sponsored by Polyphor Ltd.

2.3

Notice Coding and Classification

2.4

Total quantity or scope of tender

Contract Start : 01 July 2019

Contract End : 30 November 2019

3 Conditions for Participation

3.1

Minimum standards and qualification required

4 Administrative Information

4.1

Type of Procedure

The procedure type is unknown.

4.2

Reference number attributed to the notice by the contracting authority

QUB/1820/19

4.3

Time Limits

   02-06-2019  Time 23:59

4.5

Language or languages in which tenders or requests to participate can be drawn up

EN 

4.6

Tender Submission Postbox

5 Other Information

5.1

Additional Information

Please visit the following portal to view this notice:

https://in-tendhost.co.uk/queensuniversitybelfast/aspx/ProjectManage/1016

Date documents can be requested until : 02 Jun 2019 at 23:59 hrs

(MT Ref:293933)

5.2

Additional Documentation

5.3

Publication date of this notice

 19-04-2019

Current Notes